Comment on

• Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.

  Dodd RY, Notari EP 4th, Stramer SL. Dodd RY, et al. Transfusion. 2002 Aug;42(8):975-9. doi: 10.1046/j.1537-2995.2002.00174.x. Transfusion. 2002. PMID: 12385406
• Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.

  Pillonel J, Laperche S, Saura C, Desenclos JC, Couroucé AM; Transfusion-Transmissible Agents Working Group of the French Society of Blood Transfusion. Pillonel J, et al. Transfusion. 2002 Aug;42(8):980-8. doi: 10.1046/j.1537-2995.2002.00155.x. Transfusion. 2002. PMID: 12385407
• Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

  Velati C, Romanò L, Baruffi L, Pappalettera M, Carreri V, Zanetti AR. Velati C, et al. Transfusion. 2002 Aug;42(8):989-93. doi: 10.1046/j.1537-2995.2002.00173.x. Transfusion. 2002. PMID: 12385408
• Estimated risk of transfusion-transmitted viral infections in Spain.

  Alvarez M, Oyonarte S, Rodríguez PM, Hernández JM. Alvarez M, et al. Transfusion. 2002 Aug;42(8):994-8. doi: 10.1046/j.1537-2995.2002.00154.x. Transfusion. 2002. PMID: 12385409